fda semaglutide warning september 2025 Compounded "semaglutide" is not FDA-approved What Patients Need to Know

Ask your doctor for advice if you are taking any other medications

KEY BACKGROUND Novos semaglutide, alongside Eli Lillys tirzepatide, the drug inside blockbusters Zepbound and Mounjaro, are at the forefront of a promising class of drugs called GLP-1 agonists causing a huge stir in public health and the pharmaceutical industry

Food and Drug Administration (FDA) has approved this drug to prevent pregnancies for up to eight years

Landmark clinical trials like STEP 1, STEP 2, and STEP 3 evaluated semaglutide using once-weekly injections with gradual dose escalation

In studies assessing body composition, the weight lost with semaglutide treatment was reported to come mainly from body fat, with approximately 84.5% of weight loss from fat mass and 15.5% from lean tissue , which can include water, muscle and organs

BPC-157 is typically administered intraperitoneally at 10 g/kg or 10 ng/kg once daily, or orally in drinking water for chronic dosing protocols